UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September 10, 2020
THERMO FISHER SCIENTIFIC INC.
(Exact name of Registrant as specified in its Charter)
| | | | | | | | | | | | | | |
| Delaware | | 1-8002 | | 04-2209186 |
| (State of incorporation) | | (Commission File Number) | | (I.R.S. Employer Identification Number) |
168 Third Avenue
Waltham, Massachusetts 02451
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: (781) 622-1000
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
| | | | | | | | | | | | | | |
| Title of each class | | Trading Symbol(s) | | Name of each exchange on which registered |
| Common Stock, $1.00 par value | | TMO | | New York Stock Exchange |
| Floating Rate Notes due 2020 | | TMO /20A | | New York Stock Exchange |
| 2.150% Notes due 2022 | | TMO 22A | | New York Stock Exchange |
| 0.750% Notes due 2024 | | TMO 24A | | New York Stock Exchange |
| 0.125% Notes due 2025 | | TMO 25B | | New York Stock Exchange |
| 2.000% Notes due 2025 | | TMO 25 | | New York Stock Exchange |
| 1.400% Notes due 2026 | | TMO 26A | | New York Stock Exchange |
| 1.450% Notes due 2027 | | TMO 27 | | New York Stock Exchange |
| 1.750% Notes due 2027 | | TMO 27B | | New York Stock Exchange |
| 0.500% Notes due 2028 | | TMO 28A | | New York Stock Exchange |
| 1.375% Notes due 2028 | | TMO 28 | | New York Stock Exchange |
| 1.950% Notes due 2029 | | TMO 29 | | New York Stock Exchange |
| 0.875% Notes due 2031 | | TMO 31 | | New York Stock Exchange |
| 2.375% Notes due 2032 | | TMO 32 | | New York Stock Exchange |
| 2.875% Notes due 2037 | | TMO 37 | | New York Stock Exchange |
| 1.500% Notes due 2039 | | TMO 39 | | New York Stock Exchange |
| 1.875% Notes due 2049 | | TMO 49 | | New York Stock Exchange |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934. ☐ Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
THERMO FISHER SCIENTIFIC INC.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On September 10, 2020, Peter Hornstra, Vice President and Chief Accounting Officer of Thermo Fisher Scientific Inc. (the “Company”), notified the Company that he will retire effective March 31, 2021.
Also on September 10, 2020, the Board of Directors of the Company elected Joseph Holmes, 41, currently Senior Director of Technical Accounting, to the position of Vice President and Chief Accounting Officer of the Company, effective March 31, 2021. Mr. Holmes joined Thermo Fisher in his current role in June 2017 and leads a team that provides a broad range of accounting and finance counsel to the Company’s global finance team. Previously, Mr. Holmes served as Director, Technical Accounting and Reporting at St. Jude Medical, where his responsibilities included oversite of technical accounting, SEC reporting and internal controls, from June 2014 to January 2017, when it was acquired by Abbott Laboratories (“Abbott”), and then continued to serve in that position at Abbott from January 2017 to June 2017.
THERMO FISHER SCIENTIFIC INC.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| | | | | | | | | | | |
| | THERMO FISHER SCIENTIFIC INC. | |
| | | |
| | | |
| Date: | September 14, 2020 | By: | /s/ Michael A. Boxer |
| | | Michael A. Boxer |
| | | Senior Vice President and General Counsel |
